MedTrace Logo

Statins and ARBs on Rheumatoid Activity

NCT03770702 · Status: RECRUITING · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 45

Last updated 2018-12-10

No results posted yet for this study

Summary

Investigational and comparative study between the anti-inflammatory effectof both angiotensin reeptor blockers and statins on rheumatoid arthritis disease activity on Egyptian patients

Conditions

Interventions

DRUG

Angiotensin receptor blockers

Candesartan

DRUG

Statins

Atorvastatin

Sponsors & Collaborators

  • Sherief Abd-Elsalam

    lead OTHER

Principal Investigators

  • Sahar K Hegazy, Prof · Head of Clinical Pharmacy Department

  • Tarek M Mostafa, Prof · Prof of Clinical Pharmacy

  • Emad M Elshebini, MD · Rheumatology Dept. - Menoufia University

  • Ahmed HM El-Abd, Msc · Clinical pharmacy Department-Tanta University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-10-01
Primary Completion
2025-12-01
Completion
2026-12-01

Countries

  • Egypt

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03770702 on ClinicalTrials.gov